rdf:type |
|
lifeskim:mentions |
umls-concept:C0002976,
umls-concept:C0017262,
umls-concept:C0033414,
umls-concept:C0062534,
umls-concept:C0086418,
umls-concept:C0185117,
umls-concept:C0279626,
umls-concept:C0334227,
umls-concept:C1514475,
umls-concept:C1622501,
umls-concept:C2911684
|
pubmed:issue |
17
|
pubmed:dateCreated |
2005-9-7
|
pubmed:abstractText |
Hepatocyte growth factor/scatter factor (HGF/SF) and its receptor, c-Met, play important roles in tumor development and progression. In this study, we measured the serum HGF levels in patients with esophageal squamous cell carcinoma (ESCC) to evaluate its relationships with clinicopathologic features and the role of HGF in ESCC.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1078-0432
|
pubmed:author |
pubmed-author:CaoBrianB,
pubmed-author:ChanHiu ManHM,
pubmed-author:ChenYongxongY,
pubmed-author:CheungLeoL,
pubmed-author:HuangXinX,
pubmed-author:LawSimonS,
pubmed-author:LeePing YinPY,
pubmed-author:LukJohnJ,
pubmed-author:QuZ FZF,
pubmed-author:VALJJ,
pubmed-author:Vande WoudeGeorgeG,
pubmed-author:WongJohnJ,
pubmed-author:ZhaoPingP
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6190-7
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:16144920-Aged,
pubmed-meshheading:16144920-Carcinoma, Squamous Cell,
pubmed-meshheading:16144920-Cell Movement,
pubmed-meshheading:16144920-Disease Progression,
pubmed-meshheading:16144920-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:16144920-Esophageal Neoplasms,
pubmed-meshheading:16144920-Esophagus,
pubmed-meshheading:16144920-Female,
pubmed-meshheading:16144920-Hepatocyte Growth Factor,
pubmed-meshheading:16144920-Humans,
pubmed-meshheading:16144920-Interleukin-8,
pubmed-meshheading:16144920-MAP Kinase Signaling System,
pubmed-meshheading:16144920-Male,
pubmed-meshheading:16144920-Neovascularization, Pathologic,
pubmed-meshheading:16144920-Prognosis,
pubmed-meshheading:16144920-Proto-Oncogene Proteins c-met,
pubmed-meshheading:16144920-Tumor Markers, Biological,
pubmed-meshheading:16144920-Vascular Endothelial Growth Factor A
|
pubmed:year |
2005
|
pubmed:articleTitle |
Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas.
|
pubmed:affiliation |
Department of Surgery, University of Hong Kong Medical Centre, Queen Mary Hospital, Hong Kong, PR China. slaw@hku.hk
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|